CELMoDs – The Future of Multiple Myeloma Treatment..

새 기사를 만들었습니다

35 안에

CELMoDs – The Future of Multiple Myeloma Treatment and a Successor to REVLIMID | #healthcare

CELMoDs – The Future of Multiple Myeloma Treatment and a Successor to REVLIMID

The field of multiple myeloma treatment is advancing rapidly, with CELMoDs (Cereblon E3 Ligase Modulators) emerging as a powerful alternative to Revlimid.

처럼 싫어함

논평

공유하다